Related Experiment Video
Updated: Feb 9, 2026

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
Published on: November 6, 2010
Pathophysiology Study of Filler-Induced Blindness
Ki-Hyun Cho1, Edoardo Dalla Pozza1, Gabor Toth1
1Department of Plastic Surgery and the Cerebrovascular Center Neurological Institute, Cleveland Clinic, Cleveland, OH.
This study shows how hyaluronic acid filler can cause blindness by traveling backward into the ophthalmic artery through the supratrochlear artery in cadavers. This confirms retrograde arterial embolism as a cause of filler-induced blindness.
Area of Science:
- Ophthalmology
- Plastic Surgery
- Anatomy
Background:
- Retrograde arterial embolism is a proposed mechanism for filler-induced blindness.
- No prior human studies have confirmed this mechanism.
Purpose of the Study:
- To investigate the pathophysiology of filler-induced blindness.
- To simulate filler embolism using a fresh cadaver perfusion model.
Main Methods:
- A fresh cadaver head perfusion model was utilized, simulating physiologic blood pressure and flow rates.
- Hyaluronic acid filler, mixed with methylene blue, was injected into the supratrochlear artery.
- Techniques included cadaver dissection, angiographic study, and histology.
Main Results:
- Successful cannulation of the supratrochlear artery was achieved in all six cadavers.
- Ophthalmic artery emboli were demonstrated in three cadavers.
- Angiography confirmed filler emboli in the ophthalmic artery, showing a cut-off sign.
Conclusions:
- Retrograde hyaluronic acid filler emboli to the ophthalmic artery can be created by cannulating the supratrochlear artery.
- The superficial location and rich vasculature of the supratrochlear artery contribute to this risk.
- This cadaveric study substantiates retrograde arterial embolism as a cause of filler-induced blindness.
Related Concept Videos
Blind Procedures
Additives and Fillers in Concrete
The...
Blinding
Pneumonia II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology

